ATE262532T1 - Substituierte camptothecinderivate und verfahren zur ihrer herstellung - Google Patents

Substituierte camptothecinderivate und verfahren zur ihrer herstellung

Info

Publication number
ATE262532T1
ATE262532T1 AT96919763T AT96919763T ATE262532T1 AT E262532 T1 ATE262532 T1 AT E262532T1 AT 96919763 T AT96919763 T AT 96919763T AT 96919763 T AT96919763 T AT 96919763T AT E262532 T1 ATE262532 T1 AT E262532T1
Authority
AT
Austria
Prior art keywords
substituted
production
camptothecine
derivatives
camptothecine derivatives
Prior art date
Application number
AT96919763T
Other languages
English (en)
Inventor
Walter Cabri
Ilaria Candiani
Angelo Bedeschi
Franco Zarini
Sergio Penco
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE262532T1 publication Critical patent/ATE262532T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT96919763T 1995-05-26 1996-05-10 Substituierte camptothecinderivate und verfahren zur ihrer herstellung ATE262532T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510716.5A GB9510716D0 (en) 1995-05-26 1995-05-26 Substituted camptothecin derivatives and process for their preparation
PCT/EP1996/002008 WO1996037496A1 (en) 1995-05-26 1996-05-10 Substituted camptothecin derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ATE262532T1 true ATE262532T1 (de) 2004-04-15

Family

ID=10775098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919763T ATE262532T1 (de) 1995-05-26 1996-05-10 Substituierte camptothecinderivate und verfahren zur ihrer herstellung

Country Status (18)

Country Link
US (1) US5856333A (de)
EP (1) EP0777670B1 (de)
JP (1) JPH10503220A (de)
CN (1) CN1159192A (de)
AR (1) AR003126A1 (de)
AT (1) ATE262532T1 (de)
AU (1) AU5817996A (de)
BR (1) BR9606396A (de)
CA (1) CA2194700A1 (de)
DE (1) DE69631943D1 (de)
GB (1) GB9510716D0 (de)
HU (1) HUP9702400A3 (de)
IL (1) IL118410A0 (de)
NO (1) NO970293L (de)
NZ (1) NZ308514A (de)
PL (1) PL318279A1 (de)
WO (1) WO1996037496A1 (de)
ZA (1) ZA964138B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
GB9702807D0 (en) 1997-02-12 1997-04-02 Pharmacia & Upjohn Spa Alkynyl-substituted camptothecins and process for their preparation
WO1998035940A1 (en) * 1997-02-14 1998-08-20 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
WO1998051684A1 (en) 1997-05-15 1998-11-19 Eli Lilly And Company Antithrombotic compound
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
MXPA02008355A (es) 2000-02-28 2002-12-13 Aventis Pharma Sa Composicion que comprende camptotecina y derivado de pirimidina para tratamiento del cancer.
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6548488B2 (en) 2000-03-17 2003-04-15 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US6486320B2 (en) 2000-09-15 2002-11-26 Aventis Pharma S.A. Preparation of camptothecin and of its derivatives
EE200300184A (et) 2000-10-27 2003-08-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks
RU2004132721A (ru) 2002-04-08 2005-06-27 Глэксо Груп Лимитед (GB) (2-алкокси)фенил)циклопент-1-енил)ароматическая карбо- и гетероциклическая карбоновая кислота и ее производные
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
CN100406460C (zh) * 2003-11-10 2008-07-30 中国科学院上海药物研究所 喜树碱的新衍生物、制备方法和用途
US20090104254A1 (en) 2004-12-22 2009-04-23 Rutgers, The State University Of New Jersey Controlled Release Hydrogels
US8410045B2 (en) 2006-03-30 2013-04-02 Drais Pharmaceuticals, Inc. Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
CN101880285B (zh) * 2010-06-24 2012-07-04 华东师范大学 一种烯丙基取代喜树碱化合物的合成方法
US20140086975A1 (en) 2010-10-15 2014-03-27 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery
CN104774209B (zh) * 2014-01-15 2018-06-19 上海海和药物研究开发有限公司 一种9-烯丙基喜树碱衍生物的合成方法
AR125473A1 (es) 2021-04-29 2023-07-19 Abbvie Inc Conjugados de anticuerpo anti-c-met y fármaco

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364858A (en) * 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5340817A (en) * 1987-04-14 1994-08-23 Research Triangle Institute Method of treating tumors with anti-tumor effective camptothecin compounds
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
GB9319944D0 (en) * 1993-09-28 1993-11-17 Erba Carlo Spa Process for the preparation of 9-amino camptothecin
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation

Also Published As

Publication number Publication date
AU5817996A (en) 1996-12-11
AR003126A1 (es) 1998-07-08
EP0777670A1 (de) 1997-06-11
NO970293L (no) 1997-03-06
HUP9702400A2 (hu) 1998-06-29
PL318279A1 (en) 1997-06-09
ZA964138B (en) 1996-11-27
GB9510716D0 (en) 1995-07-19
WO1996037496A1 (en) 1996-11-28
CA2194700A1 (en) 1996-11-28
HUP9702400A3 (en) 1998-07-28
EP0777670B1 (de) 2004-03-24
JPH10503220A (ja) 1998-03-24
IL118410A0 (en) 1996-09-12
NO970293D0 (no) 1997-01-23
BR9606396A (pt) 1997-10-14
US5856333A (en) 1999-01-05
NZ308514A (en) 1998-06-26
DE69631943D1 (de) 2004-04-29
CN1159192A (zh) 1997-09-10

Similar Documents

Publication Publication Date Title
ATE262532T1 (de) Substituierte camptothecinderivate und verfahren zur ihrer herstellung
DE69527054D1 (de) Retroreflektierender gegenstand und verfahren zur herstellung
DE69322094T2 (de) Heterogene membrane und verfahren zur herstellung
DE69626833T2 (de) Ernährungsergänzungsgetränk und verfahren zur herstellung desselben
ATE216704T1 (de) Propiophenonderivate und verfahren zu ihrer herstellung
DE69623926T2 (de) Kugelgelenk und verfahren zur herstellung
DE69611599T2 (de) Halbaromatische polyamidzusamensetzung und verfahren zu ihrer herstellung
DE69819015D1 (de) Norbonenpolymer und verfahren zur herstellung
DE69620405D1 (de) Verbesserte polyarylenetherzusammensetzungen und verfahren zu ihrer herstellung
DE69524977T2 (de) Lösliche, elektroleitfähige polypyrrole und verfahren zur herstellung
ATE209208T1 (de) Zwischenprodukte und verfahren zur herstellung olanzapin
DE69625176D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung
ATE195937T1 (de) Pyridazinone-derivate und verfahren zur deren herstellung
DE69515697T2 (de) Blockcopolymere und verfahren zur herstellung
ATE231840T1 (de) Pyrrolidinylhydroxamsäuren und verfahren zu ihrer herstellung
DE69724801D1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
ATE201825T1 (de) Kompositionen mit antiviralen wirkungen und verfahren zur herstellung
DE69735099D1 (de) Antibiotika rk-1061 und verfahren zu ihrer herstellung
DE69907895D1 (de) Mastixzusammensetzung und verfahren zur ihrer herstellung
DE69527445T2 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
DE59700696D1 (de) Verfahren und zwischenprodukte zur herstellung von pyridyl-4-fluoranilinen
DE69702339D1 (de) Verfahren zur herstellung von cellulosealkanoatacetoacetaten
DE69814462D1 (de) 1,7-dibromodibenzosuberon und verfahren zur herstellung
DE4445825B8 (de) Monoalkylphosphin und Verfahren zur Herstellung desselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties